2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow GTx-024: new trials by email Literature Review of GTx-024 trials Research Report on GTx-024
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum GTx-024, placebo - Muscle Wasting, Non-Small Cell Lung Cancer | Phase 3 | Completed | GTx | 330 | 2011-07-01 | 2020-11-09 |
| Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) GTx-024, placebo - Muscle Wasting, Non Small Cell Lung Cancer | Phase 3 | Completed | GTx | 321 | 2011-07-01 | 2016-03-03 |
Carcinoma, Non-Small-Cell Lung (2) · Muscular Atrophy (2)
GTx (2)
United States (2)